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Abstract
Background: Patients with complex congenital heart defects may have different hemodynamic prob-
lems which require a variety of interventional procedures including angioplasty which involves using 
high-pressure balloons. After failure of conventional balloon angioplasty, cutting balloon angioplasty is 
the next treatment option available. The purpose of this study was to evaluate the safety and efficacy of 
cutting balloon angioplasty in children with different types of congenital heart defects. 
Methods: Cutting balloon angioplasty was performed in 28 children with different congenital heart 
defects. The indication for cutting balloon angioplasty was: pulmonary artery stenosis in 17 patients, 
creating or dilatation of interatrial communication in 10 patients, and stenosis of left subclavian artery 
in 1 patient.
Results: In the pulmonary arteries group there was a significant decrease in systolic blood pressure 
(SBP) in the proximal part of the artery from the average 74.33 ± 20.4 mm Hg to 55 ± 16.7 mm Hg  
(p < 0.001). Distal to the stenosis there was an increase in SBP from 19.8 ± 3.82 mm Hg to 30.3 ±  
± 13.3 mm Hg (p = 0.04). This result remained constant in the follow-up. In atrial septal defect/fenestra-
tion group, cutting balloon angioplasty was performed after an unsuccessful classic Rashkind procedure. 
After cutting balloon angioplasty there was a significant widening of the interatrial communication. 
Conclusions: Cutting balloon angioplasty is a feasible and effective treatment option in different con-
genital heart defects. (Cardiol J 2018; 25, 2: 165–170)
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Introduction
The use of cutting balloons (CB) in coronary 
stenoses is a common procedure in catheterization 
laboratories [1]. However, cutting balloon angio-
plasty (CBA) in congenital heart defects is not as 
frequent. Patients with complex congenital heart 
defects may have various hemodynamic problems, 
which require a variety of interventional proce-
dures including angioplasty by using high-pres-
sure balloons. The conventional balloon dilation 
technique traditionally performed to treat vessel 
stenoses can be unsuccessful in some cases [2]. 
Lack of Dacron tunnel compliance in individuals 
with Fontan circulation poses serious problems 
during the creation of percutaneous fenestration in 
patients with failing Fontan circulation. Thick, mus-
cular interatrial septum in hypoplastic left heart 
syndrome (HLHS) children can be unsusceptible 
to angioplasty in some cases. After failure of con-
ventional balloon angioplasty CBA is an important 
additional available treatment option.
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The purpose of this study was to evaluate the 
efficacy and safety of CBA in children with different 
types of congenital heart defects. 
Methods
Between October 2008 and July 2016 30 CBA 
were performed in 28 children (16 of them boys). 
Two individuals had a repeated procedure. Children 
were in the age range from 1 month to 15 years 
(mean 62 ± 67 months, median 36 months) and 
body weight ranged from 2.4 to 61 kg (mean 20.6 ± 
± 18.65 kg). 
Clinical presentation covered an expanded 
spectrum of congenital heart defects: pulmonary 
atresia with ventricular septal defect (PA+VSD) 
— 10 (35.7%) patients, HLHS — 6 (21.4%) pa-
tients, transposition of the great arteries (TGA) 
— 4 (14,3%), common arterial trunk (TAC) — 
2 (7.1%), tetralogy of Fallot (ToF) — 2 (7.1%), 
coarctation of the aorta (CoA) — 1 (3.6%) patient, 
double outlet right ventricle (DORV) — 1 (3.6%), 
tricuspid atresia (TA) — 1 (3.6%) and congenital 
severe mitral regurgitation — 1 (3.6%) patient.
Indications for CBA were the following: iat-
rogenic pulmonary arteries stenosis after Glenn/ 
/Fontan operation — 3 (9.7%) patients, iatrogenic 
pulmonary arteries stenosis after arterial switch 
operation, ToF or TAC correction — 6 (19.4%) 
patients, iatrogenic pulmonary arteries stenosis 
after unifocalization or homograft implantation — 
11 (35.5%) patients, restriction at atrial level — 
7 (22.6%) patients, failing Fontan — 3 (9.7%) pa-
tients and left subclavian artery stenosis in CoA — 
1 (3.2%) patient. 
Overall, 31 lesions were treated: atrial septal 
defect (ASD) — 7 (22.6%) patients, right pulmo-
nary artery (RPA) — 16 (51.6%), left pulmonary 
artery (LPA) — 4 (12.9%), fenestration — 3 (9.7%), 
left subclavian artery (LSA) — 1 (3.2%) patient.
More than one structure was treated by an-
gioplasty during 15 (48.4%) procedures, CBA of 
two vessels was performed in 3 of them (9.7%).
In 3 (9.7%) patients CBA was performed as an 
emergency procedure, being a planned procedure 
in the rest of the cases. 
In the majority of patients the peripheral CB 
was used (Boston Scientific, Marlborough, MA). In 
1 case AngioSculpt PTA Scoring Balloon Catheter 
(Spectranetics, Colorado Springs, CO) was used.
The diameters of cutting balloons were: 4 mm 
in 5 (16.1%) patients, 6 mm in 12 (38.7%) patients, 
7 mm in 1 patient and 8 mm in 13 (41.9%) patients.
Predilation by low pressure balloon was per-
formed in 28 (90.3%) cases for calibration and the 
adjustment of the narrowing (Fig. 1). The diameter 
of selected CB was equal or slightly larger (not 
more than 20%) compared to the diameter of the 
vessel proximal to the narrowing. After CBA the 
vessel pressures and diameters were measured 
again. If the result was suboptimal an additional 
conventional balloon angioplasty was performed 
(17 cases; 54.8%) (Fig. 2). 
In 1 case of a 15-year-old boy, ASD was success-
fully dilated by using two balloons simultaneously: 
8 mm cutting balloon and 15 mm conventional balloon 
(ASD was wider than the largest available cutting bal-
loon). In another patient, CBA was performed having 
a very good result after the failure of high-pressure 
balloon angioplasty of an in-stent restenosis.
Figure 1. A. Predilation of the right pulmonary artery in a patient post total correction (with unifocalization) of pulmo-
nary atresia, ventricular septal defect without pulmonary arteries; B. The subsequent angioplasty with cutting balloon; 
C. The final result — the optimal widening of the vessel. 
A B C
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Results
Lesions were divided into three groups: ASD/ 
/fenestrations — 10 (32.3%) patients, pulmonary ar- 
teries — 17 (54.8%) and others — 1 (3.2%) patient.
Pulmonary arteries
Cutting balloon angioplasty (17 patients, 
20 procedures) was performed in children with 
HLHS — 3, TAC — 2, PA+VSD — 11, TGA — 2, 
ToF — 2 (Table 1). In 16 (80%) of these cases pri-
mary angioplasty was performed by conventional 
balloon dilation, followed by CBA. CBA was per-
formed in 4 LPA and in 16 RPA. Post-CBA, second-
ary angioplasty by conventional or high-pressure 
balloons was performed in 11 (55%) cases.
A successful procedure was defined as achiev-
ing ≥ 50% increase in the vessel diameter and 
a significant reduction of peak systolic gradient at 
catheterization. In the present study the mean val-
ue of minimum lumen diameter (MLD) increased 
from 2.16 ± 0.72 mm to 5.6 ± 1.26 mm (p < 0.001; 
Wilcoxon test). There was a significant decrease in 
systolic blood pressure (SBP) in the proximal part 
of the vessel from the average 74.33 ± 20.4 mm Hg 
to 55 ± 16.7 mm Hg (p < 0.001). Distal to the 
stenosis there was an increase in SBP from 19.8 ± 
± 3.82 mm Hg to 30.3 ± 13.3 mm Hg (p = 0.04). 
The RV/Ao SBP ratio decreased significantly 
from 0.9 ± 0.24 to 0.59 ± 0.03 (p < 0.01). The 
Fontan patients were excluded from this analysis 
due to a different patophysiology.
In this group a high correlation (r = 0.8; 
p = 0.001; Pearson correlation) was observed be-
tween CB/MLD diameter ratio and the percentage 
increase in dimension of the dilated arteries. 
There was no significant difference in the per-
centage increase of vessel size between the group 
in which secondary angioplasty by conventional bal-
loon post-CBA was performed and the group without 
it (164.6 ± 79.6% vs. 188.35 ± 82.1%, p = 0.57).
The results of echocardiographic assessment 
of the tricuspid regurgitation maximum instan-
taneous gradient measured prior to and post-
catheterization were also compared. They revealed 
a significant decrease in tricuspid regurgitation 
Figure 2. A. The critical stenosis of the left pulmonary artery in a patient with hypoplastic left heart syndrome after 
banding of both pulmonary arteries; B. The angioplasty with a cutting balloon; C. The subsequent angioplasty with 
a high-pressure balloon; D. The final result with normalization of the diameter of the vessel.
A B
C D
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peak gradient (TRPG) from 76.1 ± 19.3 mm Hg to 
52.7 ± 17.7 mm Hg (p < 0.01; Wilcoxon test).
The first follow-up was conducted 1 month 
post-angioplasty. There was a significant decrease 
in the TRPG compared to TRPG values evaluated 
immediately post-catheterization (from 52.7 ± 17.7 
mm Hg to 42.4 ± 9.8 mm Hg, p < 0.01). A control 
echocardiographic examination was performed ap-
proximately at 6 months post-catheterization (in 
13/17 patients; 76,5%). The difference in the aver-
age value of TRGP in comparison to the previous 
examination did not reach statistical significance 
threshold (39 ± 11.5 mm Hg vs. 44 ± 18.1 mm 
Hg, p = 0.35). The results remained the same in 
the next 6-month follow-up. The diagnostic cardiac 
catheterization was performed in 6 patients 1-year 
post-angioplasty. They confirmed constant satisfying 
result: sufficiently dilated vessels, reduced pressure 
in the right ventricle and reduced pressure gradient.
Fenestration/interartial septum
Cutting balloon angioplasty (7 patients, 7 pro-
cedures) was performed in 3 (50%) patients with 
HLHS, 2 (33.3%) patients with TGA-2, 1 patient 
with PA+IVS+hypoplastic TV (16.7%) and as an 
emergency procedure in 1 neonate with severe 
congenital mitral stenosis and regurgitation. In 
this group, the indication for CBA was a severe 
restriction at the interatrial septal defect level, 
i.e. unsuccessful classic Rashkind procedure in 
neonates — 4 (57%) and the restriction of intera-
trial communication in others defects — 3 (43%). 
A significant post-procedural increase in the mean 
diameter of the interatrial communication was ob-
served: from 2.97 ± 2.03 mm to 6.94 ± 3.32 mm 
(p = 0.43). The mean transatrial gradient pressure 
significantly decreased from 9.2 ± 3.97 mm Hg to 
2.8 ± 3.18 mm Hg (p = 0.02). Also, the results of 
echocardiographic assessment of transatrial gra-
dient pressure measured prior to and post-CBA 
were compared. There was a significant fall in the 
transatrial gradient from 14.8 ± 4.2 mm Hg to 
5.2 ± 4.3 mm Hg (p < 0.001).
In 3 patients with failing Fontan physiology 
the procedures were performed successfully. In 
2 of them mechanical perforation of Fontan tun-
nel followed by dilation of the communication 
between the Fontan circuit and the left atrium 
was performed using CB. In the third patient 
a small fenestration was enlarged using an 8 mm 
CB. Immediately after the procedure, all patients 
improved and desaturated (by 6%). However, one 
of them died 2 months post-procedure due to the 
worsening of severe heart and renal failure.
There were no CBA complications except 
a single case of transient hemoptysis (3.5%) in 
a patient post-right-pulmonary-artery-angioplasty 
(previous Jatene operation). 
Table 1. Cutting balloon angioplasty (except Glenn patients) — procedural characteristics.
Sex/age 
[months]
Baseline 
diameter 
[mm]
Post-treatment  
diameter  
[mm]
Percent increase in diameter  
(% change of diameter,  
initial to final)
Initial  
RV/Ao
Final  
RV/Ao
1 M/4 1.7 5 194 n/d n/d
2 M/4 2.3 5.1 121 n/d n/d
3 M/52 4 5 25 0.73 0.57
4 F/18 2 6.2 210 1.11 0.64
5 F/30 2.3 6.8 195 1.17 0.69
6 M/7.5 1.3 3.5 169 1.08 0.7
7 M/7.5 2 3.65 82.5 n/d n/d
8 F/44 2.4 5.6 133 1.41 0.8
9 F/44 1.8 6.9 283 1.45 0.75
10 F/35 1.6 6.2 287 1.1 0.65
11 F/36 1.8 6.8 277 0.49 0.35
12 F/28 1.7 5.6 229 0.73 0.41
13 M/72 2 3.5 75 1.06 0.65
14 M/165 2.1 5.8 176 n/d n/d
15 M/94 3.7 7.5 103 0.89 0.49
16 F/43 1.9 5.5 189 1.07 0.61
Ao — aorta; F — female; M — male; RV — right ventricle; n/d — no data
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Discussion
Cutting balloon angioplasty has been described 
in pediatric patients in case reports and clinical 
studies in small groups of children. Although the 
evidence for CBA in various congenital heart 
defects is limited and indications for CBA are not 
well-established, CBA is used to treat a variety of 
lesions resistant to conventional balloon dilation, 
such as: resistant peripheral pulmonary artery 
stenosis, pulmonary vein stenosis, renal artery 
stenosis, systemic and pulmonary collateral artery 
stenosis. Based on the limited experience it has 
been suggested that the use of CBA is relatively 
safe and effective [3–8]. 
After reviewing clinical, procedural, hemody-
namic and echocardiographic data of patients who 
underwent an interventional catheterization with 
CBA, it is noteworthy to underline the heterogene-
ity of this group of children with a wide spectrum 
of congenital heart defects, both with uni- and 
bi-ventricular circulation. Experience reveals that 
CBA is a useful procedure in different clinical situ-
ations during cardiac catheterization in children. 
CB were successfully used in various types of 
peripheral pulmonary artery stenoses (post-Fontan 
procedure, unifocalization of collaterals, stenosis 
of “true” pulmonary arteries) and restrictive in-
teratrial communication, which were resistant to 
conventional balloon angioplasty. In patients with 
TGA, the intervention was guided by transesopha-
geal echocardiography, which revealed a significant 
enlargement of the interatrial communication with 
no signs of flow restriction. In addition, transatrial 
pressure gradient had decreased and peripheral 
blood saturation had increased.
In more than half of the cases the indication 
for CBA was pulmonary arteries stenosis. This 
study revealed that CBA was a safe and effective 
option for treatment in tight stenoses, especially 
those resistant to conventional balloon angioplasty. 
These results are consistent with the Bergersen et 
al. [5] randomized study. According to their study 
only 29% of pulmonary arterial stenoses were 
treated successfully with low-pressure balloons, 
52.4% with high-pressure balloons and 85.1% 
required CBA. In addition, in 55% of the vessels 
treated with high-pressure balloons the operators 
switched to CBA [5]. There was a significant rela-
tionship between the ratio of the diameter of the 
balloons used in the diameter of the stenotic part of 
the vessel and the percentage increase in the size 
of the vessel diameter. In the echocardiographic 
examination the reduction of TRPG was observed 
in the 1-month follow-up. The right ventricular 
pressure decreased and the clinical performance of 
the patients improved. Later further improvement 
is probably the effect of healing and the regression 
of edema, which was secondary to the iatrogenic 
damage done by the CBA. The follow-up was not 
long enough but the effect of the procedure re-
mained constant during this period (control cath-
eterization in 6 of the patients in a 1-year follow-up 
confirmed a stable result). Procedural success in 
patients after unifocalization and in others after 
biventricular circulation was expressed as an en-
largement of the vessel diameter and a decrease 
in the RV/Ao ratio. In patients with Glenn shunt 
CBA success was observed as an improvement 
in vessel diameter (in the majority of cases the 
measurement of pressure gradient is inadequate 
due to the development of collateral circulation 
and completely changed patophysiology).
The use of CBA both in pulmonary stenoses 
and the dilation of interatrial septal defects caused 
a significant increase in the dimensions of the dilated 
structures and an improvement in the hemody-
namic parameters analyzed in subsequent cardiac 
catheterizations and echocardiographic studies. 
According to our experience CBA proved es-
pecially useful in patients with the failing Fontan 
circulation. In this group the creation of a fenestra-
tion is especially challenging because of the low 
elasticity of the material used (Gore-Tex) for the 
interatrial baffle. Consequently, the conventional 
angioplasty was ineffective in most of them. Fur-
thermore, the use of stents (both in the atrial cavity 
and Fontan tunnel) can provoke thromboembolic 
complications due to slow flow and hepatic failure. 
Therefore, the use of CBA can be a very attractive 
alternative in this population of patients (at the cost 
of a reduced saturation). 
Cutting balloons were mainly designed for 
coronary and some peripheral vessel lesions, hence 
their use in congenital heart defects is limited 
(the largest CB is 8 mm in diameter). This limita-
tion was overcome in 1 patient (TA, PA) with the 
restrictive interatrial communication (diameter of 
5.5 mm) using the combination of an 8 mm balloon 
with a simultaneous introduction of a high-pressure 
balloon (15 mm) into the defect. The result of this 
procedure was an effective interatrial communica-
tion dilation with unrestrictive blood flow. There 
were no procedural complications. According to 
available research this was the first procedure of 
this kind. 
The next interesting application of CBA is 
in cases of in-stent restenoses. There are many 
www.cardiologyjournal.org 169
Jacek Kusa et al., Cutting balloon in congenital heart defects
available treatment options for patients with coro-
nary arteries in-stent restenoses however, in the 
population of patients with congenital heart defects 
surgery it is commonly the only one. The percuta-
neous dilation of in-stent restenoses can be very 
difficult especially for larger stents, since available 
high-pressure balloons are often inefficient and the 
procedure is far more dangerous when compared 
with the coronary arteries. In selected cases CBA 
can be used to avoid surgery.
Conclusions
Based on the results of this study it was 
concluded that CBA is safe and efficient in the 
treatment of different congenital heart defects. 
It is believed that CBA can be used as a definite 
approach in selected cases in avoiding surgery, in 
certain cases it is the only method of treatment and 
in very rare cases as a palliative option only. The 
persistence of CBA results in mid- and long term 
follow-up needs to be confirmed in larger trials.
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